Gene · 6041
Papers3,466
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,466
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biological analysis of the potential pathogenic mechanisms of Infectious COVID-19 and Guillain-Barré syndrome. | Front Immunol | 2023 | 38115996 | PubTator, text mining | PubMed |
| Activation of Protein Kinase R (PKR) Plays a Pro-Viral Role in Mammarenavirus Infected Cells. | bioRxiv | 2023 | 38106082 | PubTator, text mining | PubMed |
| Gene expression profile of HCT-8 cells following single or co-infections with Cryptosporidium parvum and bovine coronavirus. | Sci Rep | 2023 | 38092824 | PubTator, text mining | PubMed |
| Nonself RNA rewires IFN-β signaling: A mathematical model of the innate immune response. | Sci Signal | 2023 | 38085817 | PubTator, text mining | PubMed |
| The two-stage molecular scenery of SARS-CoV-2 infection with implications to disease severity: An in-silico quest. | Front Immunol | 2023 | 38077337 | PubTator, text mining | PubMed |
| Methyltransferase-like 3 (METTL3) inhibition potentiates anti-tumor immunity: a novel strategy for improving anti-PD1 therapy. | Signal Transduct Target Ther | 2023 | 38072988 | PubTator, text mining | PubMed |
| Whole exome sequencing of patients with varicella-zoster virus and herpes simplex virus induced acute retinal necrosis reveals rare disease-associated genetic variants. | Front Mol Neurosci | 2023 | 38025266 | PubTator, text mining | PubMed |
| Resurrection of 2'-5'-oligoadenylate synthetase 1 (OAS1) from the ancestor of modern horseshoe bats blocks SARS-CoV-2 replication. | PLoS Biol | 2023 | 38015855 | PubTator, text mining | PubMed |
| SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling. | bioRxiv | 2023 | 38014074 | PubTator, text mining | PubMed |
| Suppression of Innate Immunity by the Hepatitis C Virus (HCV): Revisiting the Specificity of Host-Virus Interactive Pathways. | Int J Mol Sci | 2023 | 38003289 | PubTator, text mining | PubMed |
| Toll-like receptor 7 and RIG-I-like receptors expression in peripheral blood mononuclear cells of naïve patients with hepatitis C. | BMC Res Notes | 2023 | 37993939 | PubTator, text mining | PubMed |
| Circular RNAs in renal cell carcinoma: from mechanistic to clinical perspective. | Cancer Cell Int | 2023 | 37993909 | PubTator, text mining | PubMed |
| Allosteric SHP2 inhibition increases apoptotic dependency on BCL2 and synergizes with venetoclax in FLT3- and KIT-mutant AML. | Cell Rep Med | 2023 | 37992684 | PubTator, text mining | PubMed |
| The Typical tRNA Co-Expresses Multiple 5' tRNA Halves Whose Sequences and Abundances Depend on Isodecoder and Isoacceptor and Change with Tissue Type, Cell Type, and Disease. | Noncoding RNA | 2023 | 37987365 | PubTator, text mining | PubMed |
| Copy-back viral genomes induce a cellular stress response that interferes with viral protein expression without affecting antiviral immunity. | PLoS Biol | 2023 | 37983241 | PubTator, text mining | PubMed |
| Understanding nucleic acid sensing and its therapeutic applications. | Exp Mol Med | 2023 | 37945923 | PubTator, text mining | PubMed |
| Methods for the study of ribonuclease targeting chimeras (RiboTACs). | Methods Enzymol | 2023 | 37925183 | PubTator, text mining | PubMed |
| Single-cell analysis of RNase L-mediated mRNA decay. | Methods Enzymol | 2023 | 37925178 | PubTator, text mining | PubMed |
| The regulation of antiviral innate immunity through non-m6A RNA modifications. | Front Immunol | 2023 | 37915585 | PubTator, text mining | PubMed |
| Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation. | Exp Mol Med | 2023 | 37907737 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6041/papers?page=11